Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factor Analysis and Prognostic Modelling of Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma

NCT06298123 is registered in ClinicalTrials.gov with Chen Xiaoping as lead sponsor.

NCT NCT06298123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06298123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factor Analysis and Prognostic Modelling of Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma
Lead sponsor
Chen Xiaoping
Phase
Observational
Overall status
Completed
Start date
February 1, 2019
Completion date
February 1, 2023
Enrollment
304 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant immunotherapy, checkpoint inhibitor, hepatocellular carcinoma